Description
This study will identify important barriers to and facilitators of translating an efficacious diabetes prevention intervention (Group Lifestyle Balance, GLB) into routine clinical practice, outside of a research context.
Aims include: (1) Evaluate the clinical effectiveness of GLB, (2) Evaluate the impact of GLB on healthcare utilization, costs, and cost-effectiveness, and (3) Evaluate GLB implementation within and across Sutter Health regions and clinics.
Principal Investigator
Kristen M.J. Azar, R.N., BSN, MSN/MPH, Robert Romanelli, Ph.D., MPH
Co-Investigator(s)
Sylvia Sudat, PhD, Alice R. Pressman, Ph.D., M.S.
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Start Date
April 01, 2017
End Date
March 31, 2022
Related Studies
Antimicrobial Resistant E. coli Before and After California Senate Bill 27 (ARES): A Natural Experiment
Investigator: Alice R. Pressman, Ph.D., M.S.
Assessing the Health of Chain Restaurants
Can diet- and exercise-induced weight loss improve asthma control in obese adults?
Case Management and Environmental Support to Sustain Weight Loss and Reduce CHD Risk
Culturally Adapted DPP [Diabetes Prevention Program] Intervention for Mexican Americans in Primary Care: An RCT [randomized controlled trial]
Engaging Self-Regulation Targets to Understand the Mechanisms of Behavior Change and Improve Mood and Weight Outcomes
Investigator: External PI, Principal Investigator
HOMBRE (Hombres con Opciones para Mejorar el Bienestar y bajar el Riesgo de Enfermedades crónicas)
Investigator: Kristen M.J. Azar, R.N., BSN, MSN/MPH
WAY-2-GO! Preteen Family
eCMP (electronic Cardiometabolic Program)
Investigator: Kristen M.J. Azar, R.N., BSN, MSN/MPH